Literature DB >> 25770014

A meta-analysis of induction therapy for advanced thymic epithelial tumors.

Masatsugu Hamaji1, Syed Osman Ali2, Bryan M Burt3.   

Abstract

This meta-analysis was designed to determine the effect of induction therapy and surgical resection on overall survival in patients with advanced thymic epithelial tumors. PubMed and Scopus databases were queried, and 12 studies comprising 266 patients were analyzed. Meta-analysis using a random effect model revealed a pooled rate of response to induction therapy of 59%, a pooled rate of complete resection of 73%, and pooled 5-year and 10-year overall survival of 87% and 76% after induction therapy, respectively. Surgical resection after induction therapy for advanced thymic epithelial tumors can be undertaken with favorable outcomes.
Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2015        PMID： 25770014     DOI： 10.1016/j.athoracsur.2014.12.048

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


  9 in total

1.  Multimodality therapy for locally-advanced thymic epithelial tumors: where are we now?

Authors:  Pier Luigi Filosso; Francesco Guerrera; Alberto Sandri; Enrico Ruffini
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

Review 2.  Minimal Access Surgery for Thymoma.

Authors:  Arvind Kumar; Belal Bin Asaf; Mohan Venkatesh Pulle; Harsh Vardhan Puri; Sukhram Bishnoi; Srinivas Kodaganur Gopinath
Journal:  Indian J Surg Oncol       Date:  2020-09-05

3.  The clinical benefits of immune checkpoint inhibitor for thymic carcinomas ∼experience of single public hospital in Japan∼.

Authors:  Naohiro Uchida; Kohei Fujita; Misato Okamura; Koichi Nakatani; Tadashi Mio
Journal:  Respir Med Case Rep       Date:  2018-11-13

4.  Neoadjuvant therapy for thymic neoplasms reduces tumor volume per 3D-reconstructed images but does not improve the complete resection rate.

Authors:  Jee Won Suh; Seong Yong Park; Chang Young Lee; Seung Hwan Song; Dae Joon Kim; Hyo Chae Paik; Kyoung Young Chung; Min Hee Hong; Hye Ryun Kim; Byoung Chul Cho; Jin Gu Lee
Journal:  PLoS One       Date:  2019-03-26       Impact factor: 3.240

5.  Surgical and Oncological Outcomes in Locally Advanced Thymoma.

Authors:  Arvind Kumar; Mohan Venkatesh Pulle; Belal Bin Asaf; Ganesh Shivnani; Arun Maheshwari; Harsh Vardhan Puri; Sukhram Bishnoi
Journal:  Indian J Surg Oncol       Date:  2020-09-29

6.  Does size matter? A national analysis of the utility of induction therapy for large thymomas.

Authors:  Douglas Z Liou; Divya Ramakrishnan; Natalie S Lui; Joseph B Shrager; Leah M Backhus; Mark F Berry
Journal:  J Thorac Dis       Date:  2020-04       Impact factor: 2.895

7.  Indolent stage IVA thymic malignancies managed with multimodality treatments.

Authors:  Masatsugu Hamaji
Journal:  Mediastinum       Date:  2020-06-30

Review 8.  The role of induction therapy for thymic malignancies: a narrative review.

Authors:  Deven C Patel; Joseph B Shrager; Sukhmani K Padda
Journal:  Mediastinum       Date:  2020-12-30

9.  Induction chemotherapy for locally advanced thymic epithelial tumors: consideration from the RYTHMIC prospective cohort.

Authors:  Kazuo Nakagawa
Journal:  Mediastinum       Date:  2019-04-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.